Singapore markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.9500-0.1300 (-12.04%)
At close: 01:57PM EDT
Full screen
Previous close1.0800
Open1.0800
Bid0.9600 x N/A
Ask1.0500 x N/A
Day's range0.9500 - 1.0800
52-week range0.8000 - 3.5000
Volume102,575
Avg. volume22,450
Market cap20.323M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.2720
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.75
  • CNW Group

    Eupraxia Pharmaceuticals Reports Second Quarter 2022 Financial Results

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced its unaudited financial results (prepared in accordance with International Financial Reporting Standards or "IFRS") and operational highlights for the second quarter ended June 30, 2022. All amounts are expressed in Canadian dollars unless otherwise indicated.

  • CNW Group

    Eupraxia Pharmaceuticals Recognized as Emerging Life Sciences Company of the Year by Life Sciences British Columbia

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has been awarded The Emerging Life Sciences Company of the Year Award by Life Sciences British Columbia ("LSBC").

  • CNW Group

    Eupraxia Pharmaceuticals to Present at BIO International Convention

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that its CEO, Dr. James Helliwell, will present at the 2022 Bio International Convention being held at the San Diego Convention Center from June 13-16, 2022, in San Diego, CA.